CA943067A - Potentiation of antibiotics - Google Patents

Potentiation of antibiotics

Info

Publication number
CA943067A
CA943067A CA095,832A CA95832A CA943067A CA 943067 A CA943067 A CA 943067A CA 95832 A CA95832 A CA 95832A CA 943067 A CA943067 A CA 943067A
Authority
CA
Canada
Prior art keywords
potentiation
antibiotics
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA095,832A
Other languages
English (en)
Inventor
Frederick M. Kahan
Patrick J. Cassidy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Application granted granted Critical
Publication of CA943067A publication Critical patent/CA943067A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/665—Phosphorus compounds having oxygen as a ring hetero atom, e.g. fosfomycin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA095,832A 1969-10-02 1970-10-01 Potentiation of antibiotics Expired CA943067A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86335169A 1969-10-02 1969-10-02
US7124770A 1970-09-11 1970-09-11

Publications (1)

Publication Number Publication Date
CA943067A true CA943067A (en) 1974-03-05

Family

ID=26752007

Family Applications (1)

Application Number Title Priority Date Filing Date
CA095,832A Expired CA943067A (en) 1969-10-02 1970-10-01 Potentiation of antibiotics

Country Status (7)

Country Link
BE (1) BE756953A (enExample)
CA (1) CA943067A (enExample)
DE (1) DE2048375A1 (enExample)
FR (1) FR2070104B1 (enExample)
GB (1) GB1311956A (enExample)
IL (1) IL35334A (enExample)
NL (1) NL7014541A (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH660305A5 (de) * 1984-10-05 1987-04-15 Schering Spa Wasserloesliche pharmazeutische zusammensetzungen auf der basis von salzen der (-)cis-1,2-epoxypropylphosphonsaeure mit aminosaeuren.
CH660306A5 (de) * 1984-10-05 1987-04-15 Schering Spa Wasserloesliche pharmazeutische zusammensetzungen auf der basis von salzen der (-)cis-1,2-epoxypropylphosphonsaeure mit aminosaeuren.
GB2299025B (en) * 1992-03-17 1996-11-27 British Tech Group Dispenser containing a formulation of mannose phosphate useful in the treatment of fibrotic disorders of the eye
GB9205800D0 (en) * 1992-03-17 1992-04-29 British Tech Group Treatment of fibrotic disorders
RS20050532A (sr) 2003-01-14 2007-12-31 Arena Pharmaceuticals Inc., Derivati 1,2,3-trisupstituisanog arila i heteroarila kao modulatori metabolizma za profilaksu i tretman poremećaja povezanih sa njim, kao što su dijebetes i hiperglikemija
AR045047A1 (es) 2003-07-11 2005-10-12 Arena Pharm Inc Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos
DOP2006000010A (es) 2005-01-10 2006-07-31 Arena Pharm Inc Procedimiento para preparar eteres aromáticos
MY148521A (en) 2005-01-10 2013-04-30 Arena Pharm Inc Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
CN103221410B (zh) 2010-09-22 2017-09-15 艾尼纳制药公司 Gpr119受体调节剂和对与其相关的障碍的治疗
CA3002540C (en) 2015-01-06 2023-11-07 Arena Pharmaceuticals, Inc. Use of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid for treating conditions related to the s1p1 receptor
JP6838744B2 (ja) 2015-06-22 2021-03-03 アリーナ ファーマシューティカルズ， インコーポレイテッド Ｓ１Ｐ１レセプター関連障害における使用のための（Ｒ）−２−（７−（４−シクロペンチル−３−（トリフルオロメチル）ベンジルオキシ）−１，２，３，４−テトラヒドロシクロペンタ［ｂ］インドール−３−イル）酢酸（化合物１）の結晶性Ｌ−アルギニン塩
CN110520124A (zh) 2017-02-16 2019-11-29 艾尼纳制药公司 用于治疗原发性胆汁性胆管炎的化合物和方法
JP7397011B2 (ja) 2018-06-06 2023-12-12 アリーナ ファーマシューティカルズ， インコーポレイテッド Ｓ１ｐ１受容体に関連する状態を治療する方法

Also Published As

Publication number Publication date
BE756953A (fr) 1971-04-01
FR2070104A1 (enExample) 1971-09-10
NL7014541A (enExample) 1971-04-06
FR2070104B1 (enExample) 1974-02-22
GB1311956A (en) 1973-03-28
IL35334A0 (en) 1971-04-28
IL35334A (en) 1974-01-14
DE2048375A1 (de) 1971-04-22

Similar Documents

Publication Publication Date Title
CA879784A (en) Applicator
CA921027A (en) Cephalosporins
CA969193A (en) Substituted cinnamamides
CA953450A (en) High-polymerization of ethylene
IL35334A0 (en) Potentiation of phosphonomycin antibiotics
CA957683A (en) Penicillins
CA967570A (en) Derivatives of thiourazoles
AU461004B2 (en) Synergistic antibiotics
AU454926B2 (en) Penicillins
AU453247B2 (en) Novel ethylaminopropanol derivatives
CA941822A (en) Antibiotics
CA823657A (en) Antibiotics
CA941388A (en) Isomerization of hydrindacenes
ZA706677B (en) Potentiation of antibiotics
CA812217A (en) Antibiotics
AU2238370A (en) N-arylidene derivatives of erythormycylamine
CA946284A (en) Synergistic antibiotics
CA813947A (en) Preparation of polyenes
CA811700A (en) Antibiotic fraction
CA823225A (en) Derivatives of vernamycin b
CA825162A (en) Penicillin derivatives
CA814434A (en) Penicillin derivatives
AU1293370A (en) Synergistic antibiotics
CA824150A (en) Cephalosporins
CA824854A (en) Container-integrated applicator